Level of Middle Cranial Fossa Dura in Patients With Cholesteatoma
Evaluation of the Level of Middle Cranial Fossa Dura in Patients With Cholesteatoma
1 other identifier
observational
80
0 countries
N/A
Brief Summary
Cholesteatoma is a destructive lesion that progressively expands in the middle ear, mastoid or petrous bone and leads to destruction of the nearby structures. Erosion, which is caused by bone resorption of the ossicular chain and otic capsule, may cause hearing loss, vestibular dysfunction, facial paralysis and intracranial manifestations
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2020
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 10, 2020
CompletedFirst Posted
Study publicly available on registry
September 16, 2020
CompletedStudy Start
First participant enrolled
October 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2022
CompletedSeptember 17, 2020
September 1, 2020
1 year
September 10, 2020
September 15, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Evaluation of the Level of Middle Cranial Fossa Dura in Patients with Cholesteatoma by multislice computed tomography.
determination the level of tegmen in patients with attico-antral diseases by MSCT
One year
Study Arms (1)
Patients with cholesteatoma
Patients with cholesteatoma in one ear that will compared with the other healthy one.
Interventions
Patients with cholesteatoma will undergo multislice computed tomography (MSCT) temporal bone images. Then The Tegmen level will be determined and compared with the other normal ear at the same patient
Eligibility Criteria
Patients with cholesteatoma in one ear
You may qualify if:
- All adults above the age of 18 presented to the Assiut university Clinic with
- cholesteatoma will be included in the study.
You may not qualify if:
- Patients with previous mastoid surgery
- Patients with Craniofacial anomalies or cleft lip and palate
- Pediatric populations ≤ 18 years old
- Patients with congenital ear anomalies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
September 10, 2020
First Posted
September 16, 2020
Study Start
October 1, 2020
Primary Completion
October 1, 2021
Study Completion
October 1, 2022
Last Updated
September 17, 2020
Record last verified: 2020-09